Related Experiment Videos
[Hepatocellular carcinoma--its echographic characteristics and diagnostic potentials]
Summary
Ultrasound (echography) effectively diagnoses hepatocellular cancer (HCC), even in patients with cirrhosis. This imaging method, combined with biopsy and alpha-fetoprotein levels, aids early detection and patient follow-up.
Area of Science:
- Hepatology and Medical Imaging
- Oncology and Diagnostic Ultrasound
Background:
- Hepatocellular cancer (HCC) diagnosis requires reliable imaging techniques.
- Echography is an established method for detecting focal liver lesions.
- Understanding HCC presentation in patients with and without liver cirrhosis is crucial.
Purpose of the Study:
- To evaluate the diagnostic capabilities of echography for hepatocellular cancer (HCC).
- To assess HCC diagnosis in patients with and without liver cirrhosis.
- To identify characteristic echographic features suggestive of HCC.
Main Methods:
- Echographic examination of 45 patients diagnosed with hepatocellular cancer (HCC).
- Classification of echographic images into five types: hyperechogenic, hypoechogenic, mosaic, mixed, and 'bovine eye'.
- Correlation of echographic findings with clinical data, including cirrhosis, HBsAg status, alpha-fetoprotein levels, and guided fine-needle biopsy results.
Main Results:
- Five echographic patterns were identified: hyperechogenic (29%), hypoechogenic (27%), mosaic (24%), mixed (11%), and 'bovine eye' (9%).
- Peripheral low-echogenic zones and non-homogenous mosaic tissue structure were suggestive of HCC.
- HCC presented as multiple lesions in 55.6% of patients; it was more frequently associated with cirrhosis in Bulgarian patients compared to Kuwaiti patients.
Conclusions:
- Echography is a valuable tool for the early diagnosis and systematic follow-up of HCC, particularly in patients with liver cirrhosis.
- Combining echography with guided biopsy and alpha-fetoprotein determination significantly improves diagnostic accuracy for HCC.
- Ultrasound examination plays a key role in establishing the diagnosis of HCC in diverse patient populations.